These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37883421)

  • 1. Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation.
    Liu C; Han S; Cui K; Wang F
    PLoS One; 2023; 18(10):e0287928. PubMed ID: 37883421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Closure for Atrial Fibrillation in the Elderly >75 Years Old: A Meta-Analysis of Observational Studies.
    Han S; Jia R; Zhao S; Chan J; Bai Y; Cui K
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic kidney disease on Watchman implantation: experience with 300 consecutive left atrial appendage closures at a single center.
    Xue X; Jiang L; Duenninger E; Muenzel M; Guan S; Fazakas A; Cheng F; Illnitzky J; Keil T; Yu J
    Heart Vessels; 2018 Sep; 33(9):1068-1075. PubMed ID: 29564543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis.
    Flores-Umanzor E; Asghar A; Cepas-Guillén PL; Farrell A; Keshvara R; Alvarez-Rodriguez L; Osten M; Freixa X; Horlick E; Abrahamyan L
    Clin Res Cardiol; 2023 Dec; ():. PubMed ID: 38112741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Glomerular Filtration Rates on Outcomes Following Percutaneous Left Atrial Appendage Closure.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Am J Cardiol; 2021 Apr; 145():77-84. PubMed ID: 33508268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registry.
    Fink T; Paitazoglou C; Bergmann MW; Sano M; Keelani A; Sciacca V; Saad M; Eitel C; Heeger CH; Skurk C; Landmesser U; Thiele H; Stiermaier T; Fuernau G; Reil JC; Frey N; Kuck KH; Tilz RR; Sandri M; Eitel I
    Catheter Cardiovasc Interv; 2023 Feb; 101(3):610-619. PubMed ID: 36682074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation and End-Stage Renal Disease on Hemodialysis: A Case Series.
    Basabe E; De La Flor JC; López de la Manzanara V; Nombela-Franco L; Narváez-Mejía C; Cruzado L; Villa D; Zamora R; Tapia M; Sastre MÁ; López Soberón E; Herrero Calvo JA; Suárez A; Martí Sánchez D
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
    Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
    Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage closure using WATCHMAN device in chronic kidney disease and end-stage renal disease patients.
    Jamal S; Mughal MS; Kichloo A; Edigin E; Khan MZ; Minhas AMK; Ali M; Kanjwal K
    Pacing Clin Electrophysiol; 2022 Jul; 45(7):866-873. PubMed ID: 35633309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Chronic Kidney Disease With Outcomes Following Percutaneous Left Atrial Appendage Closure.
    Ahuja KR; Ariss RW; Nazir S; Vyas R; Saad AM; Macciocca M; Moukarbel GV
    JACC Cardiovasc Interv; 2021 Aug; 14(16):1830-1839. PubMed ID: 34412801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
    Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis.
    Han Z; Wu X; Chen Z; Ji W; Liu X; Liu Y; Di W; Li X; Yu H; Zhang X; Xu B; Lan RF; Xu W
    BMC Cardiovasc Disord; 2019 Jun; 19(1):138. PubMed ID: 31182014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure.
    Nazir S; Ahuja KR; Ariss RW; Hassanein M; Schurmann P; Koneru S; Afshar H; Giorgberidze I; Moukarbel GV; Jneid H
    Catheter Cardiovasc Interv; 2021 Nov; 98(6):E839-E846. PubMed ID: 33856101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zero-Contrast Left Atrial Appendage Closure in Patients With Chronic Kidney Disease.
    Fukushima T; Fukunaga M; Isotani A; Nakamura M; Yamamoto K; Ishizu K; Morinaga T; Shirai S; Ando K
    Circ J; 2023 Dec; 88(1):170-174. PubMed ID: 38030265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term efficacy and safety of combining ablation and left atrial appendage closure: A systematic review and meta-analysis.
    Li F; Sun JY; Wu LD; Hao JF; Wang RX
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3068-3081. PubMed ID: 34453379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry.
    Fastner C; Brachmann J; Lewalter T; Zeymer U; Sievert H; Borggrefe M; Nienaber CA; Weiß C; Pleger ST; Ince H; Maier J; Achenbach S; Sigusch HH; Hochadel M; Schneider S; Senges J; Akin I
    Clin Res Cardiol; 2021 Jan; 110(1):12-20. PubMed ID: 32296971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.
    Wei Z; Zhang X; Wu H; Xie J; Dai Q; Wang L; Xu B
    Medicine (Baltimore); 2016 Aug; 95(31):e4382. PubMed ID: 27495048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.